HomeRIGL • NASDAQ
Rigel Pharmaceuticals Inc
Follow
$17.24
2.35%
After Hours:(0.00%)0.00
$17.24
Closed: Apr 4, 4:02:14 PM GMT-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 57.60M | 60.92% |
Operating expense | 29.52M | 9.94% |
Net income | 14.34M | 1,845.86% |
Net profit margin | 24.90 | 1,108.74% |
Earnings per share | 0.80 | — |
EBITDA | 17.26M | 664.01% |
Effective tax rate | 5.79% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 77.32M | 35.81% |
Total assets | 163.98M | 39.88% |
Total liabilities | 160.69M | 10.16% |
Total equity | 3.29M | — |
Shares outstanding | 17.86M | — |
Price to book | 92.92 | — |
Return on assets | 27.45% | — |
Return on capital | 44.11% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 14.34M | 1,845.86% |
Cash from operations | 14.50M | 332.42% |
Cash from investing | -10.91M | -58.77% |
Cash from financing | 1.47M | 201.44% |
Net change in cash | 5.05M | 140.02% |
Free cash flow | 1.32M | 115.58% |
Previous close
$17.66
Day range
$16.55 - $17.49
Year range
$7.48 - $29.82
Market cap
307.52M USD
Avg Volume
245.15K
P/E ratio
17.44
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
1996
Headquarters
Website
Employees
163
